CRYO — American Cryostem Income Statement
0.000.00%
Last trade - 00:00
HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $0.99m
- $0.02m
2017 September 30th | 2018 September 30th | 2019 September 30th | 2020 September 30th | 2021 September 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1.87 | 1.1 | 0.322 | 0.558 | 0.021 |
Cost of Revenue | |||||
Gross Profit | 1.31 | 0.806 | 0.29 | 0.514 | 0.007 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 3 | 2.44 | 1.26 | 1.33 | 2.74 |
Operating Profit | -1.13 | -1.34 | -0.936 | -0.771 | -2.72 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -1.22 | -1.49 | -1.08 | -1.18 | -2.88 |
Provision for Income Taxes | |||||
Net Income After Taxes | -1.22 | -1.49 | -1.08 | -1.18 | -2.88 |
Net Income Before Extraordinary Items | |||||
Net Income | -1.22 | -1.49 | -1.08 | -1.18 | -2.88 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -1.22 | -1.49 | -1.08 | -1.18 | -2.88 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.029 | -0.03 | -0.022 | -0.025 | -0.048 |